Studies pinpoint key targets for MRSA vaccine

Two studies point to a new way to a vaccinate against drug-resistant Staphylococcus aureus -- also known as MRSA -- the leading US cause of skin, soft tissue, bloodstream and lung infections, as well as deaths from infectious disease. One counteracts the bacteria's tools for evading the immune system; the other disrupts the germ's tissue-damaging mechanism. Each approach reduced the microbe's virulence in mice. The combination may protect people from MRSA and provide lasting immunity.

Read the whole article on Science Daily

More from Science Daily